Holen Sie sich die Stockscreener-App
3.68
2.13%
-0.08
Schlusskurs vom Vortag:
$3.76
Offen:
$3.78
24-Stunden-Volumen:
754.00K
Relative Volume:
0.93
Marktkapitalisierung:
$169.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-147.71M
KGV:
-1.0263
EPS:
-3.5857
Netto-Cashflow:
$-127.89M
1W Leistung:
-5.64%
1M Leistung:
+0.82%
6M Leistung:
-79.27%
1J Leistung:
-85.32%
1-Tages-Spanne:
$3.63
$3.84
1-Wochen-Bereich:
$3.59
$3.96
52-Wochen-Spanne:
$3.00
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Firmenname
Cargo Therapeutics Inc
Sektor
Branche
Telefon
650-499-8950
Adresse
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Vergleichen Sie CRGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.68 | 169.38M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.11B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 74.87B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.83B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 26.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-01-30 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-01-30 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-01-30 | Herabstufung | Truist | Buy → Hold |
| 2025-01-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-26 | Eingeleitet | William Blair | Outperform |
| 2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-12-05 | Eingeleitet | Jefferies | Buy |
| 2023-12-05 | Eingeleitet | TD Cowen | Outperform |
| 2023-12-05 | Eingeleitet | Truist | Buy |
Alle ansehen
Cargo Therapeutics Inc Aktie (CRGX) Neueste Nachrichten
CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction (NASDAQ:CRGX) - Seeking Alpha
Airline Stocks To Research – February 26th - Defense World
CARGO Therapeutics Discloses Strategic Corporate Presentation via SEC Filing - Defense World
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Layoff Tracker: Lava, Ryvu Cutting 30% of Their Workforces - BioSpace
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, IncCRGX - PR Newswire
IPOs Numbers Rise In 2024 But Dwindling Returns Could Diminish Potential In 2025 - Citeline News & Insights
CARGO Therapeutics Highlights Progress in CAR T Therapy - TipRanks
Levi & Korsinsky Reminds CARGO Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsCRGX - ACCESS Newswire
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus Price Target from Analysts - MarketBeat
After Plunging -69.58% in 4 Weeks, Here's Why the Trend Might Reverse for CARGO Therapeutics, Inc. (CRGX) - Yahoo Finance
You might want to take a look at CARGO Therapeutics Inc (CRGX) now - SETE News
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
CARGO Therapeutics, Inc. (CRGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION CARGO Therapeutics, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Shareholders to Inquire about Securities Investigation - Markets Insider
Here's Why CARGO Therapeutics, Inc. (CRGX) Could be Great Choice for a Bottom Fisher - Yahoo Finance
41,124 Shares in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Bought by abrdn plc - Defense World
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - News & Insights
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Connect - Markets Insider
Full List of Companies in California Laying Off Employees This Year - Newsweek
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Reach Out - Markets Insider
Quarterly Snapshot: Quick and Current Ratios for CARGO Therapeutics Inc (CRGX) - The Dwinnex
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Stockholders to Inquire about Securities Investigation - Markets Insider
Stock Market Movers: FOXX and AMOD Surge While CRGX and CRKN Face Sharp Declines - HPBL
Evaluating the Ups and Downs of CARGO Therapeutics Inc’s (CRGX) Stock - The News Heater
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Investors to Learn More About the Investigation - Markets Insider
Research Analysts Set Expectations for CRGX Q1 Earnings - MarketBeat
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. - GuruFocus.com
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - Longview News-Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Connect - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Did CARGO Therapeutics Inc (CRGX) perform well in the last session? - US Post News
Closing Bell Recap: CARGO Therapeutics Inc (CRGX) Ends at 3.65, Reflecting a 1.39 Upturn - The Dwinnex
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Truist Financial - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Cut to Neutral at Chardan Capital - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Neutral at HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by William Blair - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Hold at Jefferies Financial Group - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Neutral" Rating by Piper Sandler - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Lowered to "Underweight" Rating by JPMorgan Chase & Co. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - Markets Insider
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
Cargo Therapeutics stock tumbles after trial setback - MSN
HC Wainwright Expects Higher Earnings for CARGO Therapeutics - Defense World
William Blair Has Optimistic Outlook of CRGX Q1 Earnings - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Reach Out - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Sets New 1-Year Low – Here’s What Happened - Defense World
Stock summary: CARGO Therapeutics reflected weekly fall of 73.11% - Business Upturn
Finanzdaten der Cargo Therapeutics Inc-Aktie (CRGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.13%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):